Publications

2012
SLIMANI S, Abbas A, Ben-Ammar A, Kebaili D, Ali E-H, Rahal F, Abtroun-Benmadi S, Ladjouze-Rezig A. Performance Of Various Criteria Sets In Evaluating Disease Activity And Remission In RA. An Algerian Multicenter Study. Germany; 2012.
SLIMANI S, Abbas A, Ben-Ammar A, Kebaili D, Ali E-H, Rahal F, Abtroun-Benmadi S, Ladjouze-Rezig A. Performance Of Various Criteria Sets In Evaluating Disease Activity And Remission In RA. An Algerian Multicenter Study. Germany; 2012.
SLIMANI S, Abbas A, Ben-Ammar A, Kebaili D, Ali E-H, Rahal F, Abtroun-Benmadi S, Ladjouze-Rezig A. Performance Of Various Criteria Sets In Evaluating Disease Activity And Remission In RA. An Algerian Multicenter Study. Germany; 2012.
SLIMANI S, Abbas A, Ben-Ammar A, Kebaili D, Ali E-H, Rahal F, Abtroun-Benmadi S, Ladjouze-Rezig A. Performance Of Various Criteria Sets In Evaluating Disease Activity And Remission In RA. An Algerian Multicenter Study. Germany; 2012.
SLIMANI S, Abbas A, Ben-Ammar A, Kebaili D, Ali E-H, Rahal F, Abtroun-Benmadi S, Ladjouze-Rezig A. Performance Of Various Criteria Sets In Evaluating Disease Activity And Remission In RA. An Algerian Multicenter Study. Germany; 2012.
SLIMANI S, Abbas A, Ben-Ammar A, Kebaili D, Ali E-H, Rahal F, Abtroun-Benmadi S, Ladjouze-Rezig A. Performance Of Various Criteria Sets In Evaluating Disease Activity And Remission In RA. An Algerian Multicenter Study. Germany; 2012.
SLIMANI S, Abbas A, Ben-Ammar A, Kebaili D, Ali E-H, Rahal F, Abtroun-Benmadi S, Ladjouze-Rezig A. Performance Of Various Criteria Sets In Evaluating Disease Activity And Remission In RA. An Algerian Multicenter Study. Germany; 2012.
SLIMANI S, Abbas A, Ben-Ammar A, Kebaili D, Ali E-H, Rahal F, Abtroun-Benmadi S, Ladjouze-Rezig A. Performance Of Various Criteria Sets In Evaluating Disease Activity And Remission In RA. An Algerian Multicenter Study. Germany; 2012.
Boukrous H. Perspectives d’applications d’un système d’assurance qualité dans le laboratoire de biochimie CHU de Batna. Algérie; 2012.
SLIMANI S, Testas K, Makhloufi H, Ladjouze-Rezig A. Perspectives thérapeutiques dans l’arthrose. Rev Mar RhumRev Mar Rhum. 2012;22 :46-51.
SLIMANI S, Testas K, Makhloufi H, Ladjouze-Rezig A. Perspectives thérapeutiques dans l’arthrose. Rev Mar RhumRev Mar Rhum. 2012;22 :46-51.
SLIMANI S, Testas K, Makhloufi H, Ladjouze-Rezig A. Perspectives thérapeutiques dans l’arthrose. Rev Mar RhumRev Mar Rhum. 2012;22 :46-51.
SLIMANI S, Testas K, Makhloufi H, Ladjouze-Rezig A. Perspectives thérapeutiques dans l’arthrose. Rev Mar RhumRev Mar Rhum. 2012;22 :46-51.
Belambri SA, Hurtado-Nedelec M, Senator A, Makni-Maalej K, Fay M, Gougerot-Pocidalo M-A, Marie J-C, Dang PM-C, El-Benna J. Phosphorylation of p47phox is required for receptor-mediated NADPH oxidase/NOX2 activation in Epstein-Barr virus-transformed human B lymphocytes. American Journal of Blood ResearchAmerican Journal of Blood Research. 2012;2 :187.
Belambri SA, Hurtado-Nedelec M, Senator A, Makni-Maalej K, Fay M, Gougerot-Pocidalo M-A, Marie J-C, Dang PM-C, El-Benna J. Phosphorylation of p47phox is required for receptor-mediated NADPH oxidase/NOX2 activation in Epstein-Barr virus-transformed human B lymphocytes. American Journal of Blood ResearchAmerican Journal of Blood Research. 2012;2 :187.
Belambri SA, Hurtado-Nedelec M, Senator A, Makni-Maalej K, Fay M, Gougerot-Pocidalo M-A, Marie J-C, Dang PM-C, El-Benna J. Phosphorylation of p47phox is required for receptor-mediated NADPH oxidase/NOX2 activation in Epstein-Barr virus-transformed human B lymphocytes. American Journal of Blood ResearchAmerican Journal of Blood Research. 2012;2 :187.
Belambri SA, Hurtado-Nedelec M, Senator A, Makni-Maalej K, Fay M, Gougerot-Pocidalo M-A, Marie J-C, Dang PM-C, El-Benna J. Phosphorylation of p47phox is required for receptor-mediated NADPH oxidase/NOX2 activation in Epstein-Barr virus-transformed human B lymphocytes. American Journal of Blood ResearchAmerican Journal of Blood Research. 2012;2 :187.
Belambri SA, Hurtado-Nedelec M, Senator A, Makni-Maalej K, Fay M, Gougerot-Pocidalo M-A, Marie J-C, Dang PM-C, El-Benna J. Phosphorylation of p47phox is required for receptor-mediated NADPH oxidase/NOX2 activation in Epstein-Barr virus-transformed human B lymphocytes. American Journal of Blood ResearchAmerican Journal of Blood Research. 2012;2 :187.
Belambri SA, Hurtado-Nedelec M, Senator A, Makni-Maalej K, Fay M, Gougerot-Pocidalo M-A, Marie J-C, Dang PM-C, El-Benna J. Phosphorylation of p47phox is required for receptor-mediated NADPH oxidase/NOX2 activation in Epstein-Barr virus-transformed human B lymphocytes. American Journal of Blood ResearchAmerican Journal of Blood Research. 2012;2 :187.
Belambri SA, Hurtado-Nedelec M, Senator A, Makni-Maalej K, Fay M, Gougerot-Pocidalo M-A, Marie J-C, Dang PM-C, El-Benna J. Phosphorylation of p47phox is required for receptor-mediated NADPH oxidase/NOX2 activation in Epstein-Barr virus-transformed human B lymphocytes. American Journal of Blood ResearchAmerican Journal of Blood Research. 2012;2 :187.

Pages